FDA grants EUA for Hydroxychloroquine

Hydroxychloroquine is an FDA approved drug which doctors across America are legally able to prescribe registered drugs, off-label, which is different to off-label marketing. [2, @43:20]

On March 28, 2020, the FDA granted Emergency Use Authorization (EUA) to “allow hydroxychloroquine sulfate (HCQ) and chloroquine phosphate (CQ) products donated to the Strategic National Stockpile (SNS) to be distributed and used for certain hospitalized patients with COVID-19.”

Around 6 weeks later on June 15, 2020, Chief Scientist at the FDA Denise Hinton, revoked the FDA’s EUA for both CQ and HCQ curiously following the June 5th retraction of the fraudulent Lancet paper suggesting HCQ causes heart problems. [1, 3]